Evidence map›Paper›PMID 29652718›Full record

ArticleCritical care medicine2018

Translational Research: The Model Matters.

Clifford S Deutschman

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Critical care medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Beneficial effects of citrulline enteral administration on sepsis-induced T cell mitochondrial dysfunction.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Clifford S DeutschmanDepartment of Pediatrics, Hofstra - Northwell School of Medicine, Elmezzi Graduate School of Molecular Medicine and the Feinstein Institute for Medical Research, Manhasset, NY.

Funding

IL-6 AND HEPATIC DYSFUNCTION IN SEPSISR01GM059930 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI DEUTSCHMAN, CLIFFORD SCOTT · 2000 to 2009
$2.5M
Orexinergic Modulation of Experimental SepsisR01GM121102 · NIGMS · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI DEUTSCHMAN, CLIFFORD SCOTT, PAVLOV, VALENTIN ATANASSOV · 2017 to 2020
$1.6M
Creation of a conditional IL-6 knockout mouseR21AI070929 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI DEUTSCHMAN, CLIFFORD SCOTT · 2007 to 2008
$429k
NIAID NIH HHS R21 AI070929NIGMS NIH HHS R01 GM059930NIGMS NIH HHS R01 GM121102
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsSepsisAnimalsMiceProteomicsAnti-Bacterial Agents

Identifiers

PMID29652718
PMCPMC6027631

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.